Background A third of people with juvenile myoclonic epilepsy (JME) are drug-resistant.
Three-quarters have a seizure relapse when attempting to withdraw anti-seizure medication …

Purpose Juvenile myoclonic epilepsy (JME), like other forms of idiopathic generalized
epilepsy, shows a marked female predominance. However, few studies have specifically …

Introduction Sodium valproate (VPA) is the most effective antiseizure medication (ASM) in
genetic generalized epilepsies (GGEs). However, the frequent adverse effects and the high …

Abstract Background Idiopathic Generalized Epilepsy (IGE) management has become
increasingly challenging due to the restricted use of Valproate (VPA) in females. The aim of …

Introduction Juvenile Myoclonic Epilepsy (JME) is a prevalent form of epileptic disorder,
specifically categorized within the realm of Genetic Generalized Epilepsy (GGE). Its hallmark …

Common genetic generalised epilepsy syndromes encountered by clinicians include
childhood and juvenile absence epilepsies, juvenile myoclonic epilepsy and generalised …

Abstract The ILAE's Task Force on Nosology and Definitions revised in 2022 its definition of
juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy …

Background and Objectives To investigate the predictors of seizure recurrence in women of
childbearing age with idiopathic generalized epilepsy (IGE) who switched from valproate …

Métodos: Se evaluaron en forma consecutiva 100 adolescentes y adultos con EMJ que
recibían diferentes tratamientos anticrisis. Se realizó un electroencefalogra ma standard con …

Objetivo Realizar un metaanálisis de estudios observacionales y de intervención, que
analizan la proporción de pacientes con epilepsia mioclónica juvenil farmacorresistente y …